Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002333717 | SCV002633321 | uncertain significance | Inborn genetic diseases | 2020-11-03 | criteria provided, single submitter | clinical testing | The p.I15F variant (also known as c.43A>T), located in coding exon 1 of the SETX gene, results from an A to T substitution at nucleotide position 43. The isoleucine at codon 15 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003102579 | SCV003514636 | benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2022-06-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004779303 | SCV005388783 | uncertain significance | not provided | 2024-03-05 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |